Simulating drug penetration during hyperthermic intraperitoneal chemotherapy
Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after debulking cytoreductive surgery. During HIPEC, a limited number of catheters are used to administer and drain fluid containing chemotherapy (41–43 °C), yielding heterogeneities in the perito...
Main Authors: | Daan R. Löke, Roxan F. C. P. A. Helderman, Nicolaas A. P. Franken, Arlene L. Oei, Pieter J. Tanis, Johannes Crezee, H. Petra Kok |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2020.1862364 |
Similar Items
-
A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
by: Daan R. Löke, et al.
Published: (2020-11-01) -
Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model
by: Daan R. Löke, et al.
Published: (2021-01-01) -
Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review
by: Roxan F. C. P. A. Helderman, et al.
Published: (2019-01-01) -
The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
by: Roxan F.C.P.A. Helderman, et al.
Published: (2020-07-01) -
Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
by: Roxan F. C. P. A. Helderman, et al.
Published: (2021-07-01)